Determination of Optimal Dose of Gandharva Taila Bhrushta Haritaki Churna Ayurvedic Oral Preparation in the Management of Krura Koshtha (Severe Bowel Movements): A Randomised Clinical Trial Protocol

Introduction: In Ayurveda, Koshtha is defined as a bowel movement based on an individual’s basic constitution. There are three types of Koshtha-Mrudu (soft stool), Madhyam (moderate), and Krura (harsh or severe gastrointestinal nature). Individuals with Krura Koshtha are more prone to various diseas...

Full description

Saved in:
Bibliographic Details
Main Authors: Nitin Ashok Dhawas, Vaishali Kuchewar, Mohnish Gokhale
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2025-03-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/20741/72718_CE[Ra1]_F(SS)_QC(PS_SHU)_PF1(JY_SS)_redo_PFA_NC(IS)_PN(IS).pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187782930038784
author Nitin Ashok Dhawas
Vaishali Kuchewar
Mohnish Gokhale
author_facet Nitin Ashok Dhawas
Vaishali Kuchewar
Mohnish Gokhale
author_sort Nitin Ashok Dhawas
collection DOAJ
description Introduction: In Ayurveda, Koshtha is defined as a bowel movement based on an individual’s basic constitution. There are three types of Koshtha-Mrudu (soft stool), Madhyam (moderate), and Krura (harsh or severe gastrointestinal nature). Individuals with Krura Koshtha are more prone to various diseases due to improper Koshtha Shuddhi. Hence, Koshtha Shuddhi (cleansing or purifying the gastrointestinal tract) is an integral part of treatment for most diseases. Virechan (therapeutic purgation or induced bowel evacuation) is advised for Koshtha Shuddhi. Need of the Study: The action of Anulomana Dravyas (the drugs that gently stimulate downward movement in the intestines to facilitate bowel evacuation) affects the entire gastrointestinal tract. Gandharva Taila Bhrushta Haritaki is recognised as the best Anulomaka. The recommended dose of Gandharva Taila Bhrushta Haritaki Churna is described as 5-10 grams at night. Therefore, the present study is planned to confirm the optimal dose of Gandharva Taila Bhrushta Haritaki Churna for appropriate Koshtha Shuddhi in individuals with Krura Koshtha. Aim: To determine the optimal dose of Gandharva Taila Bhrushta Haritaki Churna in the management of Krura Koshtha volunteers. Materials and Methods: This is a three-armed parallel interventional trial, will be conducted in the Kayachikitsa Outpatient Department (OPD) and Inpatient Department (IPD), Mahatma Gandhi Ayurveda College, Hospital and Research Centre, Salod (H), Wardha, Maharashtra, India, from July 2024 to July 2025. A total of 90 participants who meet the inclusion criteria will be identified and randomly enrolled in three groups: Group A, Group B and Group C. Gandharva Taila Bhrushta Haritaki Churna will be administered orally to Groups A, B and C in doses of 5 grams, 7.5 grams and 10 grams, respectively, for seven days, once at bedtime. Daily follow-up will be conducted to assess Koshtha Shuddhi. Data will be analysed using the Chi-square test to find significant differences between the three groups concerning categorical variables of the Bristol stool chart, with a significance level set at p-value <0.05.
format Article
id doaj-art-42a594df50bc434e9ca83790955ed8cf
institution OA Journals
issn 2249-782X
0973-709X
language English
publishDate 2025-03-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj-art-42a594df50bc434e9ca83790955ed8cf2025-08-20T02:16:02ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2025-03-01193010310.7860/JCDR/2025/72718.20741Determination of Optimal Dose of Gandharva Taila Bhrushta Haritaki Churna Ayurvedic Oral Preparation in the Management of Krura Koshtha (Severe Bowel Movements): A Randomised Clinical Trial ProtocolNitin Ashok Dhawas0Vaishali Kuchewar1Mohnish Gokhale2Postgraduate Scholar, Department of Kayachikitsa, Datta Meghe Institute of Higher Education and Research Centre, Wardha, Maharashtra, India.Professor, Department of Kayachikitsa, Datta Meghe Institute of Higher Education and Research Centre, Wardha, Maharashtra, India.Postgraduate Scholar, Department of Kayachikitsa, Datta Meghe Institute of Higher Education and Research Centre, Wardha, Maharashtra, India.Introduction: In Ayurveda, Koshtha is defined as a bowel movement based on an individual’s basic constitution. There are three types of Koshtha-Mrudu (soft stool), Madhyam (moderate), and Krura (harsh or severe gastrointestinal nature). Individuals with Krura Koshtha are more prone to various diseases due to improper Koshtha Shuddhi. Hence, Koshtha Shuddhi (cleansing or purifying the gastrointestinal tract) is an integral part of treatment for most diseases. Virechan (therapeutic purgation or induced bowel evacuation) is advised for Koshtha Shuddhi. Need of the Study: The action of Anulomana Dravyas (the drugs that gently stimulate downward movement in the intestines to facilitate bowel evacuation) affects the entire gastrointestinal tract. Gandharva Taila Bhrushta Haritaki is recognised as the best Anulomaka. The recommended dose of Gandharva Taila Bhrushta Haritaki Churna is described as 5-10 grams at night. Therefore, the present study is planned to confirm the optimal dose of Gandharva Taila Bhrushta Haritaki Churna for appropriate Koshtha Shuddhi in individuals with Krura Koshtha. Aim: To determine the optimal dose of Gandharva Taila Bhrushta Haritaki Churna in the management of Krura Koshtha volunteers. Materials and Methods: This is a three-armed parallel interventional trial, will be conducted in the Kayachikitsa Outpatient Department (OPD) and Inpatient Department (IPD), Mahatma Gandhi Ayurveda College, Hospital and Research Centre, Salod (H), Wardha, Maharashtra, India, from July 2024 to July 2025. A total of 90 participants who meet the inclusion criteria will be identified and randomly enrolled in three groups: Group A, Group B and Group C. Gandharva Taila Bhrushta Haritaki Churna will be administered orally to Groups A, B and C in doses of 5 grams, 7.5 grams and 10 grams, respectively, for seven days, once at bedtime. Daily follow-up will be conducted to assess Koshtha Shuddhi. Data will be analysed using the Chi-square test to find significant differences between the three groups concerning categorical variables of the Bristol stool chart, with a significance level set at p-value <0.05.https://jcdr.net/articles/PDF/20741/72718_CE[Ra1]_F(SS)_QC(PS_SHU)_PF1(JY_SS)_redo_PFA_NC(IS)_PN(IS).pdfanulomakgastrointestinal tracttherapeutic purgationvirechan
spellingShingle Nitin Ashok Dhawas
Vaishali Kuchewar
Mohnish Gokhale
Determination of Optimal Dose of Gandharva Taila Bhrushta Haritaki Churna Ayurvedic Oral Preparation in the Management of Krura Koshtha (Severe Bowel Movements): A Randomised Clinical Trial Protocol
Journal of Clinical and Diagnostic Research
anulomak
gastrointestinal tract
therapeutic purgation
virechan
title Determination of Optimal Dose of Gandharva Taila Bhrushta Haritaki Churna Ayurvedic Oral Preparation in the Management of Krura Koshtha (Severe Bowel Movements): A Randomised Clinical Trial Protocol
title_full Determination of Optimal Dose of Gandharva Taila Bhrushta Haritaki Churna Ayurvedic Oral Preparation in the Management of Krura Koshtha (Severe Bowel Movements): A Randomised Clinical Trial Protocol
title_fullStr Determination of Optimal Dose of Gandharva Taila Bhrushta Haritaki Churna Ayurvedic Oral Preparation in the Management of Krura Koshtha (Severe Bowel Movements): A Randomised Clinical Trial Protocol
title_full_unstemmed Determination of Optimal Dose of Gandharva Taila Bhrushta Haritaki Churna Ayurvedic Oral Preparation in the Management of Krura Koshtha (Severe Bowel Movements): A Randomised Clinical Trial Protocol
title_short Determination of Optimal Dose of Gandharva Taila Bhrushta Haritaki Churna Ayurvedic Oral Preparation in the Management of Krura Koshtha (Severe Bowel Movements): A Randomised Clinical Trial Protocol
title_sort determination of optimal dose of gandharva taila bhrushta haritaki churna ayurvedic oral preparation in the management of krura koshtha severe bowel movements a randomised clinical trial protocol
topic anulomak
gastrointestinal tract
therapeutic purgation
virechan
url https://jcdr.net/articles/PDF/20741/72718_CE[Ra1]_F(SS)_QC(PS_SHU)_PF1(JY_SS)_redo_PFA_NC(IS)_PN(IS).pdf
work_keys_str_mv AT nitinashokdhawas determinationofoptimaldoseofgandharvatailabhrushtaharitakichurnaayurvedicoralpreparationinthemanagementofkrurakoshthaseverebowelmovementsarandomisedclinicaltrialprotocol
AT vaishalikuchewar determinationofoptimaldoseofgandharvatailabhrushtaharitakichurnaayurvedicoralpreparationinthemanagementofkrurakoshthaseverebowelmovementsarandomisedclinicaltrialprotocol
AT mohnishgokhale determinationofoptimaldoseofgandharvatailabhrushtaharitakichurnaayurvedicoralpreparationinthemanagementofkrurakoshthaseverebowelmovementsarandomisedclinicaltrialprotocol